PTPRG and chronic myelogenous leukemia, BCR-ABL1 positive: While the molecular and flow cytometry characteristics of PTPRG were studied (Vezzalini et al., 2017), the contributing epigenetic mechanisms that influence the PTPRG activity in CML patients remains unclear and warrants further investigation.